The first European Union (EU) marketing authorization for the distribution of the cyclotron-produced radiopharmaceutical gallium-68 (Ga-68) has been granted.
The Portuguese regulatory agency, INFARMED, granted the authorization to the Institute of Nuclear Sciences Applied to Health (ICNAS) from the University of Coimbra and Ion Beam Applications, which produced Ga-68 using a cyclotron.
